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The mechanisms involved in the coordinate regulation of the metabolic and structural programs controlling 
muscle fitness and endurance are unknown. Recently, the nuclear receptor PPARβ/δ was shown to activate 
muscle endurance programs in transgenic mice. In contrast, muscle-specific transgenic overexpression of the 
related nuclear receptor, PPARα, results in reduced capacity for endurance exercise. We took advantage of the 
divergent actions of PPARβ/δ and PPARα to explore the downstream regulatory circuitry that orchestrates 
the programs linking muscle fiber type with energy metabolism. Our results indicate that, in addition to the 
well-established role in transcriptional control of muscle metabolic genes, PPARβ/δ and PPARα participate 
in programs that exert opposing actions upon the type I fiber program through a distinct muscle microRNA 
(miRNA) network, dependent on the actions of another nuclear receptor, estrogen-related receptor γ (ERRγ). 
Gain-of-function and loss-of-function strategies in mice, together with assessment of muscle biopsies from 
humans, demonstrated that type I muscle fiber proportion is increased via the stimulatory actions of ERRγ 
on the expression of miR-499 and miR-208b. This nuclear receptor/miRNA regulatory circuit shows promise 
for the identification of therapeutic targets aimed at maintaining muscle fitness in a variety of chronic disease 
states, such as obesity, skeletal myopathies, and heart failure.
Introduction
Muscle fitness is an important determinant of health and disease. 
Muscle endurance, strength, and fatigability are determined by a 
variety of factors, including delivery of substrate for ATP produc-
tion, mitochondrial capacity to burn fuels, and composition of 
the contractile machinery (1–3). Although genetic factors serve to 
determine the fundamental muscle phenotype, physiological fac-
tors such as physical activity and exercise also contribute during 
the postnatal period through effects on fiber-type composition, 
mitochondrial biogenesis, and energy metabolic pathways.
Muscle fibers can be broadly classified as slow twitch (type I) 
and fast twitch (type II). Type I fibers are mitochondria-rich, rely-
ing largely on mitochondrial fatty acid oxidation for ATP produc-
tion. Type II fibers rely on glucose as an energy substrate and are 
subclassified as type IIa, IIx, or IIb in rodents based on the type 
of myosin heavy chain (MHC) isoform expressed (4, 5). Whole-
body insulin sensitivity and insulin-stimulated glucose transport 
are positively correlated with the proportion of type I muscle 
fibers (6–9). Endurance exercise training increases the propor-
tion of oxidative fibers in parallel with a mitochondrial biogenic 
response, which, in turn, increases capacity for exercise, oxidation 
of fatty acids and glucose, and energy expenditure (1–3, 10). Con-
versely, reduced physical activity, such as occurs in obese states 
and chronic illness, results in a reduction in the proportion of 
type I and IIa fibers, along with reduced muscle glucose disposal 
and insulin sensitivity (11, 12).
The mechanisms involved in the coordinate regulation of the met-
abolic and structural determinants of muscle fitness and endurance 
during development and in response to physiological stimuli are 
unknown. Recent studies in muscle-specific transgenic mice have 
provided important clues. Mice overexpressing the transcriptional 
coactivator PGC-1α exhibit increased muscle mitochondrial density 
and respiratory capacity, a greater proportion of oxidative muscle 
fibers, and enhanced exercise performance (13). Muscle-specific 
transgenes for the nuclear receptor PPARβ/δ also exhibit a “trained” 
phenotype, in which both energy metabolic and fiber-type programs 
linked to muscle endurance are activated, in the absence of exercise 
(14–16). In contrast, we recently found that muscle-specific trans-
genic overexpression of a related nuclear receptor, PPARα (MCK- 
PPARα mice), results in reduced endurance (16, 17).
The strikingly different muscle phenotypes of PPARα and 
PPARβ/δ transgenic mice suggested that the circuitry involved 
in the control of muscle endurance is differentially regulated 
in the two lines. We took advantage of the divergent actions of 
PPARβ/δ and PPARα in muscle to explore the downstream reg-
ulatory circuitry that coordinately regulates muscle fiber type 
and energy metabolism (16). We found that, in addition to the 
well-established role in the transcriptional control of energy met-
abolic genes, PPARβ/δ and PPARα participate in programs that 
exert opposing actions upon the slow-twitch type I fiber program 
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Figure 1
PPARβ/δ and PPARα regulate opposing muscle fiber-type programs. (A) Expression of the slow-twitch myosin Myh7 and representative slow/
fast-twitch troponin genes (qRT-PCR) in soleus muscle from indicated genotypes (n = 5–13 mice per group). (B) Cross-section of soleus muscle 
from 3- to 4-month-old male MCK-PPARβ/δ and MCK-PPARα mice (n = 5 mice per group) stained for myosin I ATPase activity as well as MHC 
fiber typing by immunofluorescence (IF) of soleus of indicated genotypes (MHC1 [green], MHC2a [blue], MHC2b [red], and MHC2x [unstained]). 
Scale bar: 500 μm. (C) Quantification of immunofluorescence data shown in B expressed as mean percentage total muscle fibers. (D) Muscle 
fiber typing in GC of WT and PPARα-null (PPARα KO) mice (n = 5 mice per group) as described in B. Scale bar: 500 μm. (E) Quantification of 
contractile protein gene expression in GC from indicated genotypes (n = 6–9 mice per group). (F) qRT-PCR results and Western blot analysis of 
Myh expression in skeletal myotubes harvested from WT mice subjected to adenovirus-based overexpression of PPARβ/δ shRNA (KD) compared 
with control shRNA (con) (n = 3). *P < 0.05 vs. corresponding controls. All values represent mean ± SEM and are shown as arbitrary units (AU) 
normalized to corresponding controls.
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through a distinct muscle microRNA (miRNA) network. Our 
studies also strongly suggest that the estrogen-related receptor γ/
miRNA (ERRγ/miRNA) circuitry is operational in human muscle.
Results
MCK-PPAR transgenic lines exhibit strikingly different muscle fiber-type 
phenotypes. The distinct exercise phenotypes of the two MCK- 
PPAR lines (16) afforded us the opportunity to use a comparative 
molecular profiling strategy to identify gene regulatory networks 
involved in the coordinate control of muscle energy metabolism 
and fiber type. Muscle phenotyping and transcriptional profil-
ing revealed that fiber-type programs are differentially regulated, 
at the gene regulatory level, in the MCK-PPAR lines; expres-
sion of type I genes is increased in MCK-PPARβ/δ muscle but is 
decreased in MCK-PPARα muscle (Supplemental Table 1; sup-
plemental material available online with this article; doi:10.1172/
JCI67652DS1). Gene expression validation studies demonstrated 
that the expression of the gene encoding the major slow-twitch 
type I myosin isoform MHC1 (Myh7 gene) and slow-twitch tro-
ponin genes was increased in MCK-PPARβ/δ soleus muscle, con-
comitant with a reduction in the expression of the MHC2a (Myh2), 
MHC2x (Myh1), and MHC2b (Myh4) genes (Figure 1A and data not 
shown). In striking contrast, expression of Myh7 and slow-twitch 
troponin genes was reduced in MCK-PPARα soleus muscle (Fig-
ure 1A). Similar observations were made in gastrocnemius (GC) 
muscles of the MCK-PPAR lines (Supplemental Figure 1, A and 
B). Consistent with the gene expression results, metachromatic 
ATPase and MHC immunostaining demonstrated an increase 
in MHC1-positive (type I) fibers in MCK-PPARβ/δ muscle but a 
marked reduction of MHC1-positive fibers in MCK-PPARα mus-
cle (Figure 1, B and C). These results were not due to differences 
in spontaneous locomotor activity, muscle size, or fiber density of 
the MCK-PPAR lines compared with nontransgenic (NTG) litter-
mate controls (data not shown).
Loss-of-function experiments were conducted to determine 
whether PPAR signaling is required for normal muscle fiber-type 
programming. MHC1-positive muscle fibers were significantly 
increased, together with elevated expression of slow-twitch tro-
ponin genes, in GC muscles of PPARα-null mice compared with 
those in controls (Figure 1, D and E). However, type I fiber propor-
tion was normal in PPARα-null soleus (data not shown), suggest-
ing the existence of redundant pathways in this muscle. In vitro 
manipulation of PPARα or PPARβ/δ levels in a primary skeletal 
myocyte culture system further demonstrated that the two nuclear 
receptors exert opposing effects on Myh7 expression (Figure 1F 
and Supplemental Figure 2, A and B). Taken together, these data 
demonstrate essential and opposing roles of PPARβ/δ and PPARα 
in the regulation of type I muscle fiber type.
PPAR signaling exerts control upon muscle fiber type through a specific 
miRNA network. Evidence is emerging that coordinate modulation 
of gene regulatory circuits is often directed by miRNAs (18). There-
fore, unbiased muscle miRNA profiling was conducted, unveiling 
interesting differences between the MCK-PPAR lines (Supplemen-
tal Figure 3). Two miRNAs implicated previously in muscle fiber-
type programs (19) were differentially regulated: miR-208b, which 
is encoded within the Myh7 gene, and miR-499, which is encoded 
within the Myh7b gene. miR-499 and miR-208b, which target the 
same mRNA targets, have been shown to drive a slow-twitch pro-
gram by downregulating transcriptional repressors of slow-twitch 
contractile protein genes, such as Sox6 (19, 20). Expression of miR-
Figure 2
PPARβ/δ and PPARα control distinct 
miRNA subnetworks in skeletal mus-
cle. (A and B) qRT-PCR analysis of 
Myh7/miR-208b and Myh7b/miR-
499 levels in GC muscles of indicated 
genotypes (n = 5–8 mice per group). 
Schematics at the top indicate the 
location of the miR-208b and miR-499 
genes within the Myh7 and Myh7b 
genes. Exons are denoted in the 
boxes. (C and D) Mean expression lev-
els (qRT-PCR) in myotubes harvested 
from GC of WT mice or indicated geno-
types subjected to adenovirus-based 
overexpression (OE) of PPARβ/δ 
compared with GFP control or shRNA-
mediated KD of PPARβ/δ compared 
with control shRNA (con) (n = 3). 
*P < 0.05 vs. corresponding controls. 
All values represent mean ± SEM and 
are shown as arbitrary units normal-
ized to corresponding controls.
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208b was significantly increased in MCK-PPARβ/δ muscle but was 
undetectable in MCK-PPARα muscle (Figure 2A and Supplemen-
tal Figure 3). In addition, miR-499 expression was increased in 
MCK-PPARβ/δ muscle but dramatically reduced in MCK-PPARα 
muscle (Figure 2B and Supplemental Figure 3). Similar results 
were obtained in skeletal myocytes in culture, using either trans-
genic cells or adenoviral-mediated PPAR overexpression in WT 
myocytes (Figure 2C, top). Furthermore, miR-208b and miR-499 
Figure 3
miR-208b and miR-499 mediate opposing effects of PPARβ/δ and PPARα on muscle fiber-type determination. (A) qRT-PCR analysis of Myh7 
and Myh4 transcripts in myotubes harvested from muscles of MCK-PPARβ/δ and NTG mice subjected to inhibition of miR-208b and/or miR-
499 (n = 4). (–), negative control anti-miR. (B) Muscle fiber typing, as described in the legend for Figure 1B, of soleus muscle from indicated 
genotypes (n = 5 mice per group). Scale bar: 500 μm. (C and D) Gene expression (qRT-PCR) in soleus muscle from indicated genotypes 
(n = 5–8 mice per group). (E) Mean running time and distance for indicated genotypes during endurance exercise on a motorized treadmill 
(n = 5–7 mice per group). *P < 0.05 vs. NTG. One-way ANOVA was used for statistics. All values represent mean ± SEM and are shown as 
arbitrary units normalized to corresponding controls.
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levels were increased in PPARα-null GC muscle and cultured 
myocytes (Figure 2D, top, and data not shown), whereas shRNA-
mediated knockdown (KD) of PPARβ/δ in WT myotubes reduced 
levels of miR-208b and miR-499 (Figure 2D, top). As expected, the 
expression of the Myh7 and Myh7b genes paralleled the levels of 
miR-208b and miR-499, respectively, in these studies (Figure 2).
We next assessed the effects of manipulating miR-208b and miR-
499 levels on the PPAR-mediated control of slow fiber type. First, 
the impact of antisense-mediated inhibition of miR-208b and/or 
miR-499 on MHC gene expression was evaluated in MCK-PPARβ/δ 
and NTG myotubes. Whereas inhibition of either miR-208b or 
miR-499 alone had no effect on MHC expression, inhibition of 
Figure 4
PPARβ/δ and ERRγ function cooperatively to control miR-208b and miR-499 expression. (A) The putative conserved ERR binding site within the 
Myh7 and Myh7b promoter regions. (B) ERR mRNA (GC, bottom) and ERRγ protein (GC and soleus, top) expression in muscle from indicated 
genotypes (n = 6–15 mice per group). (C) Myh transcript levels in myotubes harvested from muscles of MCK-PPARβ/δ and NTG mice subjected to 
ERRγ siRNA or scrambled control (Con) (n = 4). (D) Site-directed mutagenesis was used to abolish the ERR response element (top). The mMyh7b.
Luc.1K (WT) or ERRmut.mMyh7b.Luc.1K promoter-reporters were used in cotransfection studies in C2C12 myotubes in the presence or absence 
of ERRβ or ERRγ (n = 3) (bottom). (E) Results of SYBR green–based quantification of ERRγ ChIP assays performed on WT primary mouse myo-
tubes (n = 3). The graphs show enrichment relative (%) to input, while the schematics show PCR primer set location and the location of the putative 
conserved ERR binding sites relative to the Myh7 and Myh7b gene transcription start site (+1): –2882ERR-RE and –7ERR-RE (described in A) 
and a previously identified +20077ERR-RE (23) were analyzed. PCR primer sets located in the 2.0-kb (–2.0k) region upstream of the Myh7b pro-
moter transcription start site were used as a negative control. –10.2 k, –9.4 k, –2882, +20077, and –7 represent locations in the promoter regions 
corresponding to the transcription start site = +1. *P < 0.05 vs. corresponding controls; ‡P < 0.05 vs. control siRNA or vector alone. One-way ANOVA 
was used for statistics in C and D. All values represent mean ± SEM and are shown as arbitrary units normalized to corresponding controls.
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both miRNAs resulted in a significant decrease in Myh7 mRNA in 
WT myotubes and abolished the enhancing effects of PPARβ/δ on 
slow-twitch gene expression in MCK-PPARβ/δ myotubes (Figure 
3A). Second, to assess the relevance of this pathway in vivo, mus-
cle-specific miR-499 transgenic mice (MCK-miR-499 mice) were 
bred with the MCK-PPARα line. The resultant cross prevented the 
PPARα-mediated repression of the type I muscle fiber-type pro-
gram (Figure 3, B–D) and reversed the exercise performance deficit 
of the MCK-PPARα mice (Figure 3E). Taken together, these results 
support a model in which PPAR signaling is upstream of miR-
208b/miR-499 and that PPARβ/δ activates, whereas PPARα sup-
presses, Myh7/miR-208b and Myh7b/miR-499 expression in muscle.
The nuclear receptor ERRγ functions downstream of PPARβ/δ to acti-
vate transcription of Myh7/miR-208b and Myh7b/miR-499 in muscle. 
We next sought to determine the mechanism whereby the Myh7/
miR-208b and Myh7b/miR-499 transcripts were upregulated in the 
MCK-PPARβ/δ line. Analysis of the Myh7/miR-208b and Myh7b/
miR-499 promoter regions did not reveal consensus PPAR bind-
ing sites. However, highly conserved sequences that conformed to 
the consensus binding sites for ERR were identified in both pro-
moter regions (Figure 4A). The putative Myh7 ERR binding site 
is located well upstream of the well-described proximal promoter 
elements known to respond to the thyroid receptor, MCAT, and 
Sox6 (20, 21). Notably, ERRγ has been shown recently to activate 
oxidative muscle fiber programs in a manner similar to that of 
PPARβ/δ (14, 22). We found that ERRγ (Esrrg) mRNA and protein 
levels were increased in MCK-PPARβ/δ muscle but not in MCK- 
PPARα muscle (Figure 4B and data not shown). ERRβ (Esrrb), but 
not ERRα (Esrra), expression was also increased in MCK-PPARβ/δ 
muscle (Figure 4B). In contrast, the expression of the genes encod-
ing PGC-1α and PGC-1β, known activators of muscle endurance, 
was not increased in MCK-PPARβ/δ muscle compared with that in 
controls (Supplemental Figure 4A). siRNA-mediated KD of ERRγ 
attenuated the PPARβ/δ-mediated activation of Myh7 and Myh7b 
transcript levels (Figure 4C). In addition, ERRγ and ERRβ activated 
a 1-kb mouse Myh7b promoter-reporter via the ERR site in C2C12 
myotubes (Figure 4D). Interestingly, PGC-1α, when overexpressed 
in cells, did not have a coactivating effect on ERRγ, using the Myh7b 
promoter-reporter as a readout (Supplemental Figure 4B). ChIP 
studies confirmed that ERRγ occupies the regions of the Myh7 and 
Myh7b promoters containing the ERR-responsive elements (Figure 
4E). In addition, ERRγ occupied a putative regulatory region (based 
on ENCODE/LICR data in the UCSC Genome Browser) containing 
multiple conserved ERR response elements, approximately 10 kb 
Figure 5
ERRβ/ERRγ are required for type I muscle fiber formation. (A) miR-208b and miR-499 levels in GC muscles of indicated genotypes (n = 6 
mice per group). (B and C) Gene expression (qRT-PCR) in GC muscles from indicated genotypes (n = 6–10 mice per group). (D) Muscle fiber 
typing, as described in the legend for Figure 1B, of GC of WT and skeletal muscle–specific ERRγ/ERRβ double-deficient mice (n = 5–7 mice 
per group). Scale bar: 500 μm. (E) Mean distance (meters) traveled by 14-week-old female ERRβ/γ dmKO mice and control littermates during 
endurance (run-to-exhaustion) exercise on a motorized treadmill (n = 14 mice per group). *P < 0.05 vs. corresponding controls. All values 
represent mean ± SEM and are shown as arbitrary units normalized to corresponding controls.
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upstream of the Myh7 gene transcription initiation site (Figure 4E). 
Interestingly, these sites are markedly stronger than a previously 
identified ERR element (20077 bp downstream of the Myh7 tran-
scription start site) in heart (23).
To assess the role of ERR signaling in the miR-499/miR-208b–
mediated control of muscle fiber type in vivo, mice with skeletal 
muscle–specific disruption of the Esrrg and Esrrb genes (ERRβ/γ 
dmKO mice) were generated and analyzed (Supplemental Figure 5). 
Levels of miR-499 and miR-208b were dramatically reduced in 
ERRβ/γ dmKO GC muscle (Figure 5A). In addition, slow-twitch 
fiber gene expression and MHC1-positive fibers were reduced in 
ERRβ/γ dmKO GC muscle (Figure 5, B–D). These results were 
not due to differences in the general spontaneous activity of the 
mice or obvious pathologic changes in the muscles of the ERRβ/γ 
dmKO line. Interestingly, a change in type I fiber composition 
was not observed in the soleus muscles of the ERRβ/γ dmKO mice 
(data not shown), suggesting the existence of additional converg-
ing pathways involved in the control of fiber type in this muscle.
We next assessed acute running endurance performance in the 
ERRβ/γ dmKO line using a run-to-exhaustion protocol on a motor-
ized treadmill. Consistent with the observed alterations in muscle 
fiber-type proportion, the ERRβ/γ dmKO mice achieved a shorter 
distance compared with that of the WT controls (Figure 5E).
PPARα suppresses Myh7/miR-208b and Myh7b/miR-499 promoter 
activity. To define the mechanism by which PPARα downregulates 
miR-208b and miR-499 gene expression, transcriptional regula-
tion studies were conducted by transiently transfecting rat 3.5-kb 
Myh7 and mouse 1.0-kb Myh7b promoter-reporter constructs into 
C2C12 myotubes. In agreement with the RNA quantification data, 
cotransfection of PPARα suppressed both promoters (Supplemen-
tal Figure 6A). Interestingly, this effect occurred independently of 
exogenously added PPARα ligand. A series of deletion mapping 
studies was used to demonstrate that PPARα suppresses Myh7/
miR-208b promoter activity through a region within 408 bp 
upstream of the transcription initiation site (downstream of the 
identified ERR site) (Supplemental Figure 6B). In addition, the 
PPARα-mediated repression was maintained in a Myh7b gene pro-
moter-reporter in which the ERR-responsive element was mutated 
(Supplemental Figure 6C). Taken together, these results strongly 
suggest that PPARα suppresses Myh7/miR-208b and Myh7b/miR-
499 promoter activity independent of the ERR-responsive element. 
Given that the responsive region does not contain a classic PPAR 
DNA recognition site, it is likely that this repressive effect occurs 
via indirect mechanisms, possibly via other transcription factors 
occupying this region.
Induction of the ERRγ/miRNA axis in skeletal myotubes by chronic low-
frequency electrical stimulation. We next sought to determine whether 
this program can be activated by stimuli known to induce muscle 
type I fiber programs. Chronic low-frequency electrical stimulation 
(CLFS) of myotubes in culture has been shown to increase slow 
myosin gene expression and enhance contractile properties of mus-
cle cells in culture (24–26). Therefore, we conducted experiments 
to determine whether the ERRγ/miRNA circuit is activated in 
response to CLFS in WT mouse primary skeletal myotubes. CLFS 
for 4 days induced an increase in proportion of type I fibers (Figure 
6A) and expression of Myh7, Myh7b, miR-499, and miR-208b (Figure 
6B). In contrast, the fast fiber-type gene Myh4 was not induced by 
CLFS (data not shown). Esrrg levels, but not PPARβ/δ levels (data 
not shown), were also induced by CLFS (Figure 6B). Importantly, 
KD of ERRγ abolished the CLFS-mediated increase in Myh7, Myh7b, 
miR-499, and miR-208b (Figure 6B). These results further support 
the importance of the ERRγ/miRNA axis in type I fiber-type expres-
sion and demonstrate that it is an inducible program.
Activation of the ERRγ/miRNA axis is linked to muscle fitness in 
humans. To determine the relevance of the ERRγ/miRNA circuit 
in humans, muscle biopsies from 8 active, trained (referred to 
herein as “active”) individuals and 17 healthy sedentary controls 
were analyzed. Previous analyses demonstrated that the biopsy 
specimens from the “active” group contain a higher percentage 
of type I muscle fibers compared with those from the sedentary 
Figure 6
The ERRγ/miRNA circuit is induced 
by CLFS in skeletal myotubes in 
culture. (A) MHC fiber typing by 
immuno fluorescence in CLFS or 
unstimulated myotubes (MHC1 
[green], MHC2b [red]). Scale bar: 
200 μm. Quantification of the 
immuno fluorescence data shown 
on the left expressed as mean 
percentage total myotubes (n = 5). 
(B) qRT-PCR analysis of Myh7/
miR-208b, Myh7b/miR-499, and 
Esrrg levels in CLFS and unstimu-
lated mouse myotubes subjected to 
ERRγ siRNA or scrambled control 
(Con) (n = 3). *P < 0.05 vs. corre-
sponding controls. One-way ANOVA 
was used for statistics in B. All val-
ues represent mean ± SEM and are 
shown as arbitrary units normalized 
to corresponding controls.
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group (Supplemental Table 2 and ref. 27). As expected, muscle 
tissue from the “active” group exhibited higher slow-twitch gene 
(MYH7 and MYH7B) expression compared with that from the sed-
entary control group (Figure 7A). Expression levels of ESRRG and 
miR-499 were also significantly elevated in the “active” group com-
pared with those in the controls (Figure 7A). In addition, there 
was a significant positive correlation between ESRRG mRNA levels 
and both MYH7B and MYH7 mRNA levels (Figure 7B). Moreover, 
ESRRG mRNA levels were positively correlated with miR-499 levels 
(Figure 7B). However, this correlation was not observed with miR-
208B levels (Figure 7B).
The relationship between ESRRG expression and levels of the 
miRNAs with determinants of muscle endurance (type I fiber 
percentage, VO2max, and ATPmax) was next assessed. As shown in 
Figure 7C, a strong positive correlation was observed between the 
expression of miR-499 and type I fiber percentage, ATPmax, and 
VO2max. ESRRG expression also correlated with type I fiber per-
centage, ATPmax, and VO2max. In contrast, the levels of PPARD and 
PPARA mRNA were not different between sedentary and “active” 
muscle, and neither exhibited a significant correlation with fiber 
type, ATPmax, or VO2max (Supplemental Figure 7). Taken together, 
these results strongly suggest that the ERRγ/miR-499 axis is oper-
ative in the regulation of the type I muscle program in humans.
Discussion
Type I muscle fibers are equipped with a high-capacity mitochon-
drial system and a distinct set of contractile protein isoforms 
poised for endurance. The circuitry involved in the coordinate 
control of these seemingly distinct but highly interrelated pro-
cesses is unknown. Recently, a clue was provided when the nuclear 
receptors PPARβ/δ and ERRγ, transcriptional regulators of cellu-
lar energy metabolism (28), were independently shown to drive 
Figure 7
ERRγ/miRNA axis is associated with muscle contractile and metabolic properties in humans. Samples from 5 to 8 “active” and 15 to 17 healthy 
sedentary controls were used for this analysis. (A) mRNA expression levels of MYH7B, MYH7, ESRRG, miR-499, and miR-208B were deter-
mined by qRT-PCR. Data represent the mean ± SEM. Significant differences were analyzed using 2-sample t test. *P < 0.05 vs. sedentary controls. 
(B) Correlation between ESRRG gene expression and that of muscle contractile genes, miR-499, and miR-208B. Spearman correlation analysis 
was used to determine the correlation. (C) Correlation between ESRRG and miR-499 expression and the type I fiber percentage, ATPmax, and 
VO2max. Pearson correlation analysis was used to determine the correlation.
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fiber program by downregulating the expression of transcriptional 
repressors, including Sox6 and Purb, which, in turn, suppress slow-
twitch genes (19, 20, 32–36).
We found that ERRγ serves a critical role in this regulatory net-
work by directly activating transcription of the Myh7 (miR-208b) 
and Myh7b (miR-499) genes via highly conserved ERR-responsive 
elements. The expression of ERRγ and the related ERRβ (but not 
ERRα) is elevated in MCK-PPARβ/δ muscle through mechanisms 
that remain unknown. Interestingly, the results of our studies 
using myotubes in culture suggest that activation of the type I 
fiber program by PPARβ/δ occurs via a ligand-independent mech-
anism (data not shown). The mouse ERRγ has at least two differ-
ent promoters. We have found that the activity of both promoters 
is increased in MCK-PPARβ/δ muscle, with the transcript driven 
by the downstream promoter exhibiting the greatest increase in 
MCK-PPARβ/δ muscle (data not shown). Using informatics search 
approaches, we have not been able to identify conserved PPAR 
binding motifs (37, 38) in potential regulatory regions in the 
DNA sequence spanning from approximately –100 kb upstream 
to approximately 50 kb downstream of the ERRγ downstream 
promoter transcription initiation site. Thus, we conclude that 
activation of ERRγ by PPARβ/δ likely occurs via an indirect mech-
anism. In addition, it is possible that PPARβ/δ and ERRγ interact 
at other levels, including, but not limited to, cooperating (directly 
or indirectly) to activate transcription of type I fiber genes. Our 
results also suggest that the ERRγ/β-driven muscle fiber-type pro-
gram does not require the transcriptional coactivator PGC-1α, 
which has been shown to regulate fiber type, likely in response to 
endurance training (13, 39–43). However, it would seem likely that 
with certain physiological conditions, such as exercise, induction 
of PGC-1 could further enhance the mechanism described herein 
by coactivating PPARβ/δ. Taken together, our results suggest the 
existence of a regulatory network, as shown in Figure 8.
Muscle fiber-type proportion is determined by both fundamen-
tal developmental mechanisms and postnatal physiological stim-
uli, such as exercise training (1–3). The tissue-selective promoters 
used in the generation of gain-of-function (PPAR transgene) and 
loss-of-function (Esrrg/Esrrb gene knockout) mouse lines for this 
study are both active during prenatal development, suggesting 
that the mechanisms described may be capable of driving funda-
mental fiber-type determination. However, the results of our CLFS 
studies in cell culture indicate that this nuclear receptor/miRNA 
regulatory circuit is inducible. Interestingly, we found that ERRγ 
is required for the CLFS-triggered induction of this program. In 
addition, our survey of the human muscle samples also demon-
strated that the ERRγ/miR-499 circuit was activated in the “active” 
group. Specifically, ESRRG and miR-499 levels were higher in mus-
cle samples obtained from trained “active” individuals compared 
with those of sedentary individuals. We also found that the expres-
sion of ESRRG and miR-499 was strongly correlated with fiber-type 
proportion, expression of MYH7 and MYH7B genes, and measures 
of enhanced exercise performance (including VO2max). However, we 
did not see similar correlations with PPARD or PPARA expression 
in humans. This could relate to species differences. Alternatively, 
the programs directed by PPARA and PPARD in humans may not 
be manifest in the “active”-versus-sedentary group comparison, 
because this pathway is primarily involved in other genetic pro-
grams (e.g., fundamental developmental programs). Given that we 
did not conduct a longitudinal training study in humans or mice, 
our results do not allow us to determine whether this regulatory 
an increase in slow oxidative fiber composition and vascularity 
in mice (14, 22, 29–31). Herein, we show that PPARβ/δ and ERRγ 
function to activate transcription of the Myh7 and Myh7b genes, 
increasing the levels of miR-208b and miR-499 and, thereby, trig-
gering a cascade of muscle slow-twitch contractile protein gene 
expression (19, 20). The related nuclear receptor PPARα sup-
presses the activating effects of PPARβ/δ/ERRγ on Myh7/miR-208b 
and Myh7b/miR-499.
Muscle endurance is determined by multiple factors, including 
capacity for mitochondrial fuel oxidation and ATP synthesis, fiber-
type mix, and vascularity (1–3). The inducible transcriptional coac-
tivator PGC-1α was shown previously to coordinately trigger these 
programs in muscle-specific transgenic mice (13). Thereafter, mus-
cle transgenes for PPARβ/δ and ERRγ, known transcription factor 
targets of PGC-1, were shown to exhibit a trained muscle pheno-
type, including increased expression of well-established PPAR/
ERR target genes involved in mitochondrial energy transduction 
and oxidative phosphorylation, together with an increased pro-
portion of type I fibers (14, 16, 22, 29–31). We sought to delin-
eate the regulatory circuitry linking the activation of energy met-
abolic genes with the fiber-type program by taking advantage of 
the markedly different muscle phenotypes of the MCK-PPARα 
and MCK-PPARβ/δ lines. Using a combination of gene expression 
and miRNA profiling, we found that ERRγ/ERRβ and miR-208b/
miR-499 levels were increased in parallel with expression of type I 
fiber genes in the muscle of MCK-PPARβ/δ mice. In striking con-
trast, miR-208b/miR-499 levels were suppressed in MCK-PPARα 
muscle, together with a lack of induction of ERRγ and ERRβ and 
suppression of the type I program. These results were intriguing 
given the recent discovery that miR-208b and miR-499 are embed-
ded in slow-twitch MHC genes and serve to activate slow-twitch 
Figure 8
Model of nuclear receptor/miRNA circuit in the coordinate control of 
energy metabolism and muscle fiber type. The schematic depicts a pro-
posed model for a nuclear receptor/miRNA circuit that controls muscle 
type I fiber-type program. ERRγ (and likely ERRβ) activates miR-208b 
and miR-499, triggering a type I fiber program, while PPARα sup-
presses the program. The effect of exercise could stimulate this program 
via the transcriptional coactivator PGC-1α and possibly via ERRγ/β.
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confirmed that the fiber-type switch phenotype was similar in pure B6 mice 
compared with that in the hybrid MCK-PPAR mice (data not shown).
Human studies. Details on subject characteristics and procedures have 
been described previously (27) and are provided in Supplemental Table 2. 
Briefly, mitochondrial capacity, as measured by ATPmax, was determined on 
a 3T GE Signa MNS magnet (GE) using a 4- or 6-cm 31P-tuned surface coil 
positioned over the distal vastus lateralis. For maximum aerobic capacity 
(VO2max), cardiorespiratory testing was conducted in the Exercise Testing 
Core, using a standardized graded exercise testing protocol on a station-
ary bicycle ergometer (Lode Excalibur). After an overnight fast and local 
anesthesia, skeletal muscle was collected from the vastus lateralis muscle, 
cleaned, and mounted for fiber typing as described previously (27) or flash 
frozen in liquid nitrogen for RNA isolation.
Exercise studies. Endurance exercise was determined as described previously 
(16) with the following exception. Fed mice were run for 10 minutes at 10 
meters per minute followed by a constant speed of 20 meters per minute 
until exhaustion. For assessment of ERRβ/γ dmKO mouse running capac-
ity, mice were run for 45 minutes at 15 meters per minute at 5% incline, fol-
lowed by an increase of 2 meters per minute every 15 minutes until exhaus-
tion (defined as remaining on the shock grid for more than 1 minute).
Histologic analyses. Muscle tissue was frozen in isopentane that had been 
cooled in liquid nitrogen. MHC ATPase and immunofluorescence stains 
were conducted as previously described (39, 50). MHC ATPase stains were 
performed at pH 4.31. Under these acidic conditions, MHC2 isoforms are 
inactivated while MHC1 is still functional, resulting in addition of black dye 
to MHC1-positive muscle fibers. For immunofluorescence stains, the fibers 
were quantified (MHC1, green; MHC2a, blue; MHC2x, black [unstained]; 
MHC2b, red) and expressed as relative numbers of the different fiber types.
TLDA array. Total RNA isolated from soleus muscles of 3-month-old 
MCK-PPARα (HE) or MCK-PPARβ/δ (HE) mice and NTG littermates 
using the RNAzol method (Tel-Test) was used for the gene expression array. 
TaqMan Rodent microRNA Arrays v2.0 (A and B) (Applied Biosystems) 
were performed by the Sanford-Burnham Medical Research Institute Ana-
lytical Genomics Core. For miRNA cDNA synthesis, 1 μg RNA was reverse 
transcribed using the miRNA Reverse Transcription Kit in combination 
with the stem-loop Megaplex Primer Pool (Applied Biosystems) in a total 
of 7.5 μl volume. Quantitative real-time PCR was performed using the 
Applied Biosystems 7900HT system and a TaqMan Universal PCR Mas-
ter Mix, with 6 μl cDNA input per plate using the following conditions: 
10 minutes at 94.5°C followed by 40 cycles of 97°C for 30 seconds and 
59.7°C for 1 minute. Real-Time StatMiner Software from Integromics was 
used for the data analysis, and mouse snoRNA202 was used as endogenous 
control for data correction. Ct values greater than 30 in both NTG and 
MCK-PPAR mice were excluded. Fold change was calculated by the 2−ΔΔCt 
method using averaged values from 3 trials. The relative miRNA level was 
normalized to NTG control. A moderated t test was performed to identify 
significance, as defined by the following criteria: P value less than 0.01 and 
fold change greater than 2 (either direction).
RNA analyses. Real-time quantitative RT-PCR was performed as described 
previously (16). Specific oligonucleotide primers for target gene sequences 
are listed in Supplemental Table 3. Arbitrary units of target mRNA were 
corrected to expression of 36b4 or GAPDH. The gene expression array and 
miRNA array data have been deposited in NCBI’s Gene Expression Omni-
bus (GEO) and are accessible through GEO accession numbers GSE5777, 
GSE29055, and GSE36498 (miRNA array).
TaqMan miRNA. Total RNA was isolated from mouse muscle or pri-
mary myotubes using the RNAzol method (Tel-Test) for miRNA assay. 
Total RNA from human muscle biopsy specimens was extracted using the 
RNeasy Mini Kit and the miRNeasy Mini Kit (Qiagen). TaqMan methods 
were used to assess miRNA expression. Briefly, 10 ng RNA (for skeletal 
pathway is involved in the response to endurance training or deter-
mination of fundamental fiber type during development. Obvi-
ously, these are not mutually exclusive roles, and future studies 
will be necessary to further delineate the function of this pathway 
in response to physiological inputs.
The upstream regulatory mechanisms that link inputs, such as 
developmental cues or exercise, to the network defined here are 
unknown. Evidence has emerged that exercise induces a switch in 
the relative abundance of transcriptional corepressor complexes, 
such as the nuclear receptor corepressor 1/histone deacetylase 
(NCoR1/HDAC) (44, 45) complex, and coactivator complexes 
containing inducible factors, such as PGC-1α (13, 39–43), at the 
regulatory regions of key genes that control muscle mitochon-
drial function and fiber type. Interestingly, NCoR1/HDAC– and 
PGC-1α–containing cofactor complexes are known to corepress 
or coactivate ERRs (44, 46, 47) and PPARs (44, 47, 48), respectively, 
thereby suggesting a mechanism whereby the pathways described 
here could be dynamically modulated. In addition, the transcrip-
tional coregulator MED13 was recently shown to control metab-
olism downstream of miR-208a in heart, suggesting additional 
potential control mechanisms (49).
Surprisingly, in contrast to miR-499, miR-208b levels were not 
higher in the “active” muscle compared with those in control. The 
reason for this difference compared with the results in the mouse 
lines is not clear. This could reflect a species-specific posttran-
scriptional regulatory effect. Indeed, evidence is emerging that 
RNA processing, including but not limited to alternative splicing 
and RNA degradation, are highly active and regulated in muscle. 
It is tempting to speculate that such mechanisms are active in 
human muscle such that the miR-208b steady-state levels are not 
increased in humans.
In summary, we have identified a gene regulatory pathway, 
involving nuclear receptor and miRNA signaling, which is involved 
in the coordinate control of muscle energy metabolism and fiber 
type. Increased proportion of type I fibers and enhanced mito-
chondrial function are linked to improved glucose tolerance 
and insulin sensitivity (6–9). Conversely, obesity and chronic 
disease states, such as heart failure, result in detrained muscle, 
with reduced numbers of oxidative muscle fibers and diminished 
fuel-burning capacity. Therefore, the regulatory network described 
here shows promise as a candidate target for new therapeutic 
approaches aimed at coordinately increasing muscle type I fibers 
and energy metabolic capacity.
Methods
Animal studies. Esrrg- and Esrrb-floxed (ERRγ/ERRβL2/L2) mice were generated 
at the Mouse Clinical Institute in Strasbourg according to a strategy previ-
ously described (44) and back-crossed to the C57BL/6JBomTac background 
for 10 generations. To generate mice with skeletal muscle–specific deletions 
of the ERRγ/ERRβ alleles (herein referred to as ERRβ/γ dmKO mice), ERRγ/
ERRβL2/L2 mice were crossed to human skeletal actin–Cre (HSA-Cre) mice. 
PPARα-null (Ppara–/–) mice in the C57BL/6J background were purchased 
from The Jackson Laboratory (stock no. 008154). High-expressing (HE) 
MCK-PPAR mice have been previously described (16, 17). C3B6F1 MCK-
miR-499 mice (19) were bred with MCK-PPARα mice to generate the MCK- 
PPARα/miR-499 double-transgenic mice. The MCK-PPARα mice are in a 
C57BL/6J pure strain and MCK-PPARβ/δ mice are in a hybrid B6/CBA back-
ground, with the following specific exceptions: hybrid MCK-PPAR mouse 
lines were used in Figure 3 (C3/B6) and Supplemental Table 1 (B6/CBA). 
NTG littermate controls were used in all cases. Of note, fiber-type analyses 
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ChIP assays. ChIP assays were performed as previously described (16). 
Briefly, primary myotubes were cross-linked with 1% formaldehyde 
(10 minutes), and cells were collected and lysed. Chromatin fragmentation 
was performed by sonication using a Bioruptor (Diagenode). Proteins were 
immunoprecipitated by using anti-ERRγ or IgG control (Sigma-Aldrich). 
Following reversal of crosslinking, DNA was isolated (QIAquick PCR Puri-
fication Kit, Qiagen). QPCR products were assessed and measured using 
the Stratagene MX3005P detection system. Quantitative analysis was per-
formed by the standard curve method. Specific oligonucleotide primers for 
target regions are listed in Supplemental Table 4.
Statistics. All mouse and cell studies were analyzed by 2-tailed Student’s 
t test or 1-way ANOVA coupled to a Fisher’s least significant difference 
post-hoc test when more than 2 groups were compared. Data represent the 
mean ± SEM, with a statistically significant difference defined as P < 0.05. 
Statistical analyses in human studies were performed using JMP 9.0.0 (SAS 
Institute Inc.), and values are presented as mean ± SEM. Gene expression 
levels in human studies were analyzed using the Spearman correlation or 
Pearson correlation test. Significant differences were defined as P < 0.05.
Study approval. After signing the informed written consent approved by 
the Pennington Biomedical Research Center (PBRC) ethical review board, 
patients were enrolled the in clinical trial performed in Baton Rouge, Lou-
isiana, USA, at the PBRC. Volunteers qualified for the study (ACTIV; Clin-
icaltrials.gov ID NCT00401791) if they ranged in age from 20 to 40 years, 
had a BMI of 20 to 30 kg/m2, were nondiabetic, took no medications, and 
were otherwise healthy. Animal studies were conducted in strict accordance 
with the NIH guidelines for humane treatment of animals and approved by 
the IACUC committees at Sanford-Burnham Medical Research Institute at 
Lake Nona and The Scripps Research Institute at La Jolla.
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muscle) or 50 ng RNA (for primary myotubes) was reverse transcribed to 
cDNA with the TaqMan MicroRNA Reverse Transcription Kit and the 
TaqMan MicroRNA Assays specific for each miRNA (Assay ID: hsa-miR-
208b, 2290; mmu-miR-499, 1352; has-miR-499, 1045) or for the internal 
controls (Assay ID: snoRNA202, 1232; RNU48, 1006) (Applied Biosys-
tems). Thermal cycling was performed on an Applied Biosystems 7900HT 
system. The relative miRNA level was corrected to snoRNA202 or RNU48.
Antibodies and immunoblotting studies. Antibodies directed against MHC1 
(BA-D5), MHC2b (BF-F3), and MHC2a (SC-71) were purchased from the 
Developmental Studies Hybridoma Bank; anti-ERRγ antibody was pro-
vided by Ronald Evans (Salk Institute for Biological Studies, San Diego, 
California, USA); anti-GAPDH antibody was purchased from Abcam; anti-
body directed against S6 ribosomal protein (S6RP) was purchased from 
Cell Signaling Technology. Western immunoblotting studies were per-
formed as previously described (16).
Cell culture. Primary muscle cells were isolated from skeletal muscles as pre-
viously described (16). C2C12 cells were cultured at 37°C and 5% CO2 in Dul-
becco’s modified Eagle’s medium supplemented with 10% fetal calf serum. 
For differentiation, cells were washed with PBS and refed with 2% horse 
serum/DMEM differentiation medium and refed daily. Primary myoblasts 
were infected with an adenovirus overexpressing GFP, PPARβ/δ, PPARα, 
ERRγ, GFP shRNA, or PPARβ/δ shRNA as previously described (16, 51). 
Twelve hours after infection, cells were induced to differentiation for 3 days.
Electric pulse stimulation. CLFS was applied to primary mouse myotubes 
with a S88X stimulator (Grass Technologies). This instrument provides 
a positive phase followed by a negative phase of identical duration and 
voltage. During the 1-s trains, a 200-ms pulse stimulus with 2.5 V and a fre-
quency of 2 Hz was applied. The contractions of the myotubes were verified 
by examination under microscope. Primary myotubes were stimulated for 
4 hour per day for 4 days.
Manipulation of miR-208b and miR-499 in primary skeletal myotubes. For inhi-
bition of miR-208b and/or miR-499, validated miRCURY LNA microRNA 
Power Inhibitors (has-miR-499-5p: ACATCACTGCAAGTCTT; has-miR-
208b: ACAAACCTTTTGTTCGTCTT; and a negative control A: GTGTAA-
CACGTCTATACGCCCA) were purchased from Exiqon and transfected 
into primary myoblasts at a final concentration of 20 to 50 nM using 
HiPerFect Transfection Reagent (Qiagen) according to the manufacturer’s 
instructions. Twelve hours after transfection, cells were induced to differ-
entiation for 3 days.
RNAi experiments. siRNAs (ON-TARGET plus SMARTpool, Dharmacon) 
targeting mouse Esrrg were transfected into primary myoblasts at a final 
concentration of 20 nM using HiPerFect Transfection Reagent (Qiagen) 
according to the manufacturer’s instructions. Cells were then differenti-
ated for 3 days prior to harvest.
Cell transfection and luciferase reporter assays. pSG5, pSG5-ERRβ, pSG5-
ERRγ, pBOS, pBOS-PPARα, pcDNA3.1, and pcDNA3.1-PGC-1α vectors 
have been described previously (16, 52). The 1.0-kb mouse Myh7b pro-
moter-reporter (32) vector was provided by Leslie Leinwand (University 
of Colorado, Boulder, Colorado, USA). The rat Myh7 promoter constructs 
(53) were provided by Kenneth Baldwin (University of California, Irvine, 
California, USA). Site-directed mutagenesis was performed using the Quik-
Change Kit (Stratagene) according to the manufacturer’s protocol, using 
complementary oligonucleotides as follows (with mutated nucleotides 
shown in bold and with lowercase letters): 5′-GCTGTTGTCAgatctAG-
CAAAGGAG (Myh7b ERRmut). Transient transfections in primary myo-
blasts or C2C12 cells were performed using Attractene Transfection 
Reagent (Qiagen) as per the manufacturer’s protocol. Luciferase assay was 
performed using Dual-Glo (Promega) according to the manufacturer’s rec-
ommendations. All transfection data are presented as the mean ± SEM for 
at least 3 separate transfection experiments performed in triplicate.
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